FGF21 and obesity due to melanocortin 4 receptor deficiency: Fibroblast growth factor 21 (FGF-21), a new endocrine hormone with the regulatory effects on energy homeostasis and metabolism of lipid and glucose, has been known to inhibit the inflammation and cell damage caused by oxidative stress in obesity and insulin-resistant states including NAFLD [13].